Dr. Simona Rossi, MD

Dr. Rossi practices at Virtua Home Care at West Jersey in Marlton, New Jersey.

Dr. Rossi's NPI, 1831158005, was assigned on March 17, 2006. Dr. Rossi graduated from Georgetown University School of Medicine in 1998. Dr. Rossi holds New Jersey license 25MA09863200.

Dr. Rossi's primary practice is Virtua Home Care at West Jersey, at 301 Lippincott Drive - 2nd Floor, Marlton, NJ 08053. The practice phone is (856) 581-7200.

Dr. Rossi's primary practice is Virtua Home Care at West Jersey in Marlton, New Jersey. Dr. Rossi is also affiliated with Christiana Hospital. The medical group on file is Virtua Medical Group. Dmand AI also links Dr. Rossi to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Rossi's employer is on file too: a home health agency.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rossi practices, 9 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Rossi's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dmand AI has Dr. Rossi's licenses on file in 3 states: New Jersey, Delaware and Pennsylvania.

CMS data shows 358 Medicare services from Dr. Rossi across 7 procedure codes in 2024, for 211 Medicare patients. Medicare paid $34,007 for them.

CMS counts 211 Medicare patients who saw Dr. Rossi in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rossi's median patient age at 62, with 55% women.

In 2024, Dr. Rossi wrote 635 Medicare Part D claims for 139 patients. 81% of them were for generic drugs. CMS names the drug for 512 of them, across 13 drugs with 11 or more claims each, at $286,535 in total drug cost. In 2023, CMS named 462 claims across 14 drugs.

Dr. Rossi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rossi as offering telehealth. CMS counts 17 procedures of colonoscopy by Dr. Rossi, more than 46% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 71 papers to Dr. Rossi, published from 2010 to 2025. 2019 was the busiest year, with 9. The most frequent topics are MicroRNAs, Cell Line, Tumor and Placenta. Dr. Rossi has published most often in Front Immunol. Dr. Rossi's most frequent co-authors are Cristina Simona Ivan, MD, Dionysios Neofytos, MD and Jawad Ahmad, MD.

Dmand AI links Dr. Rossi to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Hepatitis, Alcoholic, Hepatitis B, Chronic and Liver Cirrhosis, Biliary.

CMS Open Payments shows 179 general payments to Dr. Rossi from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Gilead Sciences, Inc. paid the most, $140,822. It also lists 1 research payment totaling $525 in 2022.

Dr. Rossi graduated from Georgetown University School of Medicine in 1998.